Oxonol is a chewable tablet made by Real Botanicals, featuring an enhanced alkaloid extract centered on a compound called MGM-15, also known as dihydro-7-hydroxymitragynine. If you've been using 7-OH products and noticed Oxonol on the shelf next to them, that's the short answer for why it's there: same category, different active compound, different regulatory position.
This guide covers what Oxonol actually is at the chemistry level, how it was developed, how it compares to 7-OH on real-world measures, and what the buying decision looks like for someone choosing between the two. Where relevant, we'll link out to primary sources and to our own product pages for context.
The Name, the Molecules, and Why Both Matter
"Oxonol" is the brand name Real Botanicals uses for this product line. You won't find it in published scientific literature on kratom, because the word identifies a commercial formulation rather than a specific chemical compound. The tablet contains two active ingredients: MGM-15, a well-documented semi-synthetic molecule derived from 7-hydroxymitragynine, and mitragynine, the most abundant naturally occurring alkaloid in kratom.
MGM-15 is produced by modifying 7-OH at a specific position in its molecular structure, which changes how the compound binds to receptor sites and changes its effect profile. Research on the broader mitragynine analog family has been published through channels including the National Center for Biotechnology Information (NCBI) and the broader NIH research system. For a plain-language breakdown of MGM-15 itself, see our ”What Is MGM-15?” guide.
Since it occurs naturally, mitragynine is not chemically altered but is simply extracted from the plant. It is responsible for many of the familiar effects of kratom, including energy, mental clarity, mood support, and easing discomfort.

How Oxonol Is Made
Real Botanicals starts with sustainably sourced Mitragyna speciosa leaf from trusted Indonesian growers. Mitragynine is extracted and purified using our proprietary ChromaPure process, which uses liquid chromatography to isolate individual alkaloids without harsh solvents. From there, MGM-15 is produced in a controlled laboratory setting and formulated into the finished tablet.
Each Oxonol tablet for sale is manufactured in a cGMP-certified U.S. facility and scored for easy splitting. Every batch is third-party lab tested for alkaloid content and contaminant screening, and the results are published as Certificates of Analysis on our site. The tablet itself is chewable, strawberry-flavored, and designed to work in fractional servings. Most users start with half a tablet and see how their body responds before going higher.
Oxonol vs 7-OH: Specifics, Not Generalities
The conversation around Oxonol and 7-OH tends to get muddy because both compounds sit in the same product category and produce broadly similar effects. The differences matter. Here's the side-by-side.
|
Factor |
7-OH (7-Hydroxymitragynine) |
Oxonol (MGM-15 + mitragynine) |
|
Origin |
Naturally occurring alkaloid in kratom leaf, present at trace amounts (<0.1% of total alkaloid content) |
Naturally occurring kratom alkaloid + semi-synthetic compound derived from 7-OH |
|
Molecular structure |
Indole alkaloid with hydroxyl group at the 7-position |
Indole alkaloid with complex structure + modified structure with an added hydrogen pair (dihydro) on 7-OH |
|
Onset |
Fast, typically 15 to 30 minutes |
Fast, with a smoother initial climb |
|
Duration |
Shorter, more peaked effect curve |
Longer sustain with a level profile |
|
Regulatory status |
Restricted in several U.S. states under concentrated-kratom rules |
Structurally distinct, falls outside most state 7-OH restrictions |
|
Tolerance behavior |
Builds with frequent use |
Builds with frequent use; cross-tolerance with 7-OH is possible |
|
Available formats at Real Botanicals |
10mg / 20mg / 40mg / 100mg tablets plus 30mg shot |
30mg / 60mg chewable tablets |
|
Best for |
Users wanting fast peak effects, multiple strength options, liquid format option |
Users wanting longer sustain, legal availability across more states, tablet format with fine splitting |
The honest take: Oxonol was designed specifically to sit next to 7-OH in the catalog, not to replace it. Customers who already use 7-OH and like it don't need to switch. Customers in restricted states, customers who want a longer-sustained session, and customers looking to rotate activities to manage tolerance all have a real reason to try Oxonol specifically. For a complete profile breakdown, see MGM-15 vs 7-OH: Which Kratom Alkaloid Is Right for You?

What the Experience Is Actually Like
User feedback on Oxonol clusters around a few themes. The onset tends to feel smoother rather than sharp. The body effect is described as grounded and even, rather than front-loaded. The duration is longer than a 7-OH session at comparable serving sizes, which some users welcome while others find it overkill for short-window use cases.
None of that is a guarantee of any specific experience. Individual response varies based on metabolism, prior kratom exposure, hydration status, and what else you've consumed that day. The general pattern of feedback is worth knowing, but the only way to know how a given compound works for you is to start at the lowest recommended serving and pay attention.
Does Oxonol Show Up on a Drug Test?
Standard 5-panel and 10-panel employment drug screenings do not test for kratom components or derivatives directly. Those panels screen for specific drug classes (opioids, amphetamines, cannabinoids, etc.) based on the chemical markers common to each class. MGM-15, mitragynine, and 7-OH are chemically distinct from pharmaceutical opioids and don't produce those markers. For a complete breakdown on 7-OH and drug tests, see our user guide.
Specialized kratom-specific tests do exist and would flag kratom alkaloids and their metabolites. If you're subject to workplace testing, athletic testing, or legal monitoring that includes custom panels, the right move is to check with whoever administers the test before using any kratom-related product. We can tell you what's in the tablet. We can't tell you what tests your specific employer or agency runs.
Related read: Does Kratom Show Up as an Opiate?

Legal Status and Why It Matters
Several U.S. states have moved on concentrated 7-OH in the past two years, typically under rules that name 7-hydroxymitragynine specifically or address concentrated kratom extracts more broadly. MGM-15 is a structurally distinct compound from 7-OH, which puts Oxonol outside the scope of most of those rules. For current state-by-state status on both, see our 7-Hydroxymitragynine Legality Guide.
This is not a forever-guarantee that Oxonol will remain legal in any given state. Regulatory environments around kratom and its analogs continue to develop. What we can tell you is that Oxonol was engineered with the current legal framework in mind, and Real Botanicals tracks state-level changes closely.
If you want to understand the broader alternatives category beyond just Oxonol, see How to Find the Best 7-OH Alternatives – like these Pseduoindoxyl Tablets for sale by Real Botanicals.
Who Oxonol Is Actually For
The honest answer: Oxonol is a 7-OH alternative product for experienced adults who already understand how concentrated kratom extracts behave. It is not a starting point for kratom use generally. If you've never used kratom, Super Kratom Capsules at 75mg or the Kratom Kava Shot are where that conversation should begin.
If you have used concentrated extracts before, whether 7-OH products, pseudoindoxyl, or any high-MIT standardized kratom, Oxonol is a reasonable next step. The smaller tablet counts (3-tablet packs) let you test without committing to a full case.
Start with half a tablet. Wait the full onset window before deciding whether to take more. Don't stack it with alcohol or sedatives. Take rest days between sessions. None of that is new advice, and all of it is in the product labeling, but it's worth repeating because new users who ignore it are the ones most likely to have a bad first session.

Oxonol Frequently Asked Questions
What is Oxonol?
Oxonol is Real Botanicals' brand name for a chewable tablet containing MGM-15 (dihydro-7-hydroxymitragynine), a semi-synthetic compound derived from 7-hydroxymitragynine, and mitragynine, a naturally occurring kratom alkaloid. It's formulated as a legal alternative to 7-OH in states that have restricted concentrated kratom extracts.
What does Oxonol feel like?
Users describe a smooth, fast onset followed by a longer sustain than comparable 7-OH sessions. The effect character is often described as grounded and even across the body rather than sharply peaked. Individual response varies, and any concentrated alkaloid product should be started at the lowest recommended serving.
Does Oxonol get you high?
Oxonol is a botanical supplement, not a recreational substance, and Real Botanicals markets it as such. The effects users report are consistent with other advanced kratom alkaloids and include feelings of calm and ease with sustained focus when the product is used at suggested servings. Taking more than the recommended serving does not produce a better experience and increases the risk of unwanted side effects.
Is Oxonol stronger than 7-OH?
It depends on how you measure. 7-OH often delivers a more peaked, shorter-duration effect. Oxonol delivers a longer, more level effect at its labeled serving. Comparing milligram to milligram isn't the right way to think about it because the two compounds produce different experiences. Neither is universally stronger.
Is Oxonol legal in my state?
In most U.S. states, yes, because MGM-15 is chemically distinct from 7-OH and falls outside the scope of most state-level 7-OH restrictions. Regulatory frameworks continue to evolve, so check our 7-OH Legality Guide for the current status before ordering.
Can Oxonol become habit-forming?
Any concentrated kratom extract carries dependence potential with regular, high-dose use. The National Institute on Drug Abuse discusses this directly in its kratom research overview. Staying within labeled servings, taking rest days, and not combining with other depressants meaningfully reduces risk.
Disclaimer
This information is educational only. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare provider before use.